e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Distinguishing phenotypes and dealing with comorbidities in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutrophils and the increased risk of cardiovascular events in severe COPD
K. Yazaki, N. Kamada, Y. Fujibe, M. Kashima, K. Asakura, M. Sato, T. Sato, K. Kikuchi (Yuri-Honjo, Akita, Japan)
Source:
Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Session:
Distinguishing phenotypes and dealing with comorbidities in primary care
Session type:
Thematic Poster Session
Number:
3702
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Yazaki, N. Kamada, Y. Fujibe, M. Kashima, K. Asakura, M. Sato, T. Sato, K. Kikuchi (Yuri-Honjo, Akita, Japan). Neutrophils and the increased risk of cardiovascular events in severe COPD. Eur Respir J 2012; 40: Suppl. 56, 3702
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
COPD and respiratory viral infections as risk factors for the development of cardiovascular events
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
The impact of airway infection on cardiovascular risk during COPD exacerbations
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018
The risk of cardiovascular disease associated with asthma may be mediated by short-acting β
2
-agonists
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Acute exacerbation in COPD and relationship between cardiovascular risk and functional profile
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018
The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020
The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Exacerbations in severe persistent asthma - impact of risk factors control
Source: Eur Respir J 2005; 26: Suppl. 49, 683s
Year: 2005
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept